SECsense Logo

Radiopharm Theranostics Limited: February 2025 Form 6-K SEC Report Highlights

$RADX
Form 6-K
Filed on: 2025-02-18
Source
Radiopharm Theranostics Limited: February 2025 Form 6-K SEC Report Highlights

Here are the key points extracted from the provided section of the financial report:

  1. Document Type: The report is a Form 6-K, which is used by foreign companies to furnish information to the SEC.
  2. Company Information:
  • Name: Radiopharm Theranostics Limited
  • Commission File Number: 001-41621
  • Address: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
  1. Reporting Period: The report is for the month of February 2025.
  2. Public Notice: On February 18, 2025, the company announced its participation in the "B Riley Securities Radiopharma Conference." This announcement was made to the Australian Securities Exchange.
  3. Exhibit Included: The report includes an exhibit (Exhibit 99.1) which contains the details of the public notice regarding the company's participation in the conference.
  4. Regulatory Compliance:
  • The report specifies that it shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934 and will not be incorporated by reference into any filing under the Securities Act of 1933, unless expressly stated.
  1. Signature: The report is signed by Phillip Hains, the Company Secretary, on February 18, 2025.

This information is essential for understanding the context of the company's activities and compliance with reporting requirements under U.S. securities laws.